AB INITIO BUILDING AUSTRALIA’S NEXT GENERATION PHARMACEUTICAL ENGINE

Discover how Ab Initio Pharma is helping shape Australia’s pharmaceutical ecosystem in this recent ARCS Australia Cognito interview with CEO Paul Young.

 
 
Next
Next

Ab Initio researchers publish feature article on upper respiratory in vitro models for improved IVIVC